DnB Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$678K Hold
2,927
– – ﹤0.01% 690
2026
Q2
$705K Hold
2,927
– – ﹤0.01% 693
2026
Q1
$553K Buy
+2,927
New +$512K ﹤0.01% 737

Other funds holding JAZZ

DnB Asset Management's JAZZ Position: Q3 2026 in Review

DnB Asset Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2026 at 2,927 shares worth $678K. The position accounts for ﹤0.01% of the portfolio, ranked #690.

DnB Asset Management first reported a position in JAZZ in Q1 2026 and has held it in 3 quarters since. The position peaked at $705K in Q2 2026. 670 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • DnB Asset Management held 2,927 shares of Jazz Pharmaceuticals worth $678K as of Q3 2026.
  • DnB Asset Management left its Jazz Pharmaceuticals share count unchanged in Q3 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of DnB Asset Management's portfolio in Q3 2026, its #690 holding.
  • DnB Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • DnB Asset Management's Jazz Pharmaceuticals position peaked at $705K in Q2 2026.
  • 670 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on DnB Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.